Clinical Trials Directory

Trials / Completed

CompletedNCT00716586

Treatment of Cystoid Macular Edema in Patients With Retinal Degeneration

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
44 (actual)
Sponsor
University of Illinois at Chicago · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A small percentage of patients with retinal degeneration accumulate fluid in the center of their retina. Previous studies using an oral form of treatment has been successful in decreasing this fluid which improves vision. This study will test the use of a topically applied form of this treatment to the eye to reduce the amount of fluid and improve or preserve vision.

Detailed description

Patients with certain retinal degenerations will be asked to take part in a research study about the use of a topically applied eye drop for treating fluid in the central part of the retina (macular edema). In the current study, investigators propose to use topical Trusopt in a group of patients with retinal degeneration (RD) to determine its effectiveness in reducing the amount of retinal fluid in patients with RD and macular edema. The methods will involve an initial one month treatment with topical Trusopt three times a day in each eye. After a period of one month, patients will return for a follow-up examination. At baseline, they will have had a measurement of their center vision and a measurement of their macular fluid with a photographic-like procedure termed optical coherence tomography (OCT). After the one month period of treatment, they will again have a measurement of their vision and re-evaluation with OCT. An improvement at least of one line (7 letters) or more of vision will be considered as a clinically significant improvement.

Conditions

Interventions

TypeNameDescription
DRUG2% dorzolamideCarbonic anhydrase inhibitor, Trusopt (2% dorzolamide)

Timeline

Start date
2005-10-01
Primary completion
2015-08-11
Completion
2017-11-17
First posted
2008-07-16
Last updated
2021-10-29
Results posted
2021-10-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00716586. Inclusion in this directory is not an endorsement.

Treatment of Cystoid Macular Edema in Patients With Retinal Degeneration (NCT00716586) · Clinical Trials Directory